Banner

The Digest of Anti-Aging and Stem Cell Research 

 

April /May 2011
In This Issue
Stem Cells Injection Repairs Hearts
Aggressive Multiple Sclerosis
Age-Related Eyesight Degeneration
Immune System Treatments
Parkinson's Disease Progress
Join Our Mailing List
Past Issues
Dear  Friends,

I hope spring finds you in good health and good spirits! As usual, science is buzzing along finding all kinds of ways to rejuvenate and repair our bodies. You'll find some information below about new research and developments in research for people and other animals.

 

Next month we'll be giving you a special report from the North American Veterinary Regenerative Medicine Association's (NAVRMA) second annual meeting in Lexington, Kentucky, June 2-4. At this conference, veterinarians will be discussing the latest research as well as their own success with stem cell treatments. I can't wait to learn more about what they're doing in this exciting new field.

 

Meanwhile, you might enjoy watching our second video interview about stem cell treatments for pets right here in Dallas. As always, if there is information you need for your pet or yourself about stem cell research, clinical trials, and treatments, please let us know. 
 

Sincerely,
Susan Schmidt
Editor
Medicine for a New Era
A division of the Global Peace Project

Follow
Link to us through these popular social media sites:

 View our profile on LinkedIn Follow us on Twitter Find us on Facebook

 


 
Animal News & Research

NEW MEDIA

 

Older golden retrieverVideo: What Can Veterinary Stem Cells Do for My Pet?

 

Click through to the MFNE website for the second in our series of interviews about stem cell treatments in Dallas veterinary offices. In it, we talk about a case study of a golden retriever currently being treated for arthritis.

 

Click here to access the video.

 
Human News & Research
Direct Injection of Stem Cells Repairs Injured Hearts 

Stem cell researchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue, and improved function to injured heart areas.

BalanceStem Cell Treatments for MS Show Long-Term Benefit     
Stem cell treatments for multiple sclerosis (MS) gained support last month with the publication of a study that proved the long-term benefits of regenerative therapy on a particularly aggressive form of the disease.
  
Treating Age-Related Macular Degeneration      Aging Skin

Researchers at Georgetown University have demonstrated for the first time the ability to regenerate cells in the retina by using adult stem cells.
  

Researchers Create Stem Cells to Treat Immune Disorder  

 

Researchers from the National Institute of Allergy and Infectious Disease (NIAID) at the National Institutes of Health (NIH) and The Johns Hopkins University School of Medicine have genetically reprogrammed bone marrow stem cells into induced pluripotent stem cells (iPS) without the use of carrier viruses.

 

Read the rest of the story. 

Feature Article

Stem Cells Reverse Disease in a Model of Parkinson's Disease

Researchers from the United States and Korea have used cells derived from different types of human stem cell to reverse Parkinson's disease in a rat model. They announced in The Journal of Clinical Investigation that they have identified a stem cell population that they believe could be clinically relevant. 

In the recent study, doctors Sang-Hun Lee from Hanyang University's medical school (Korea) and Kwang-Soo Kim from McLean Hospital and Harvard University (Boston) used induced pluripotent stem cells (iPS cells)-adult cells that have been reprogrammed back to a state from which they can develop into other human cells. Human cells can be reprogrammed to become iPS cells in one of two ways: cells can be injected directly with reprogramming proteins (protein-based iPS cells) or viruses can be used to deliver

to the cells the genetic information necessary for producing the reprogramming proteins (virus-based iPS cell).

 

Scientists in this study found several problems with cells derived from virus-based human iPS cells that precluded their use in the Parkinson's disease model but found that nerve cells derived from protein-based human iPS cells reversed disease when transplanted into the brain of rats modeling Parkinson's disease. They therefore conclude that protein-based human iPS cells could be used in the treatment of individuals with Parkinson's disease and project: "Our results suggest that protein-based reprogramming may be a viable approach for generating a patient-specific source of cells for treatment of [Parkinson's disease] and other degenerative diseases."